| Control Group (N=35) | Aperture Group (N=33) | |
|---|---|---|
| Mean age at surgery, years | 63.1 ± 11.3 | 64.4 ± 10.6 |
| Operative side | ||
| Right | 19 | 12 |
| center | 16 | 21 |
| Gender | ||
| Male | 21 | 16 |
| Female | 14 | 17 |
| Body Mass Index, kg/m2 | 31.1 ± 6.1 | 32.0 ± 5.6 |
| Total ankle replacement type | ||
| Primary | 10 | 18 |
| Revision | 25 | 15 |
| Comorbidities | ||
| Type II diabetes | 8 | 5 |
| Rheumatoid arthritis | 1 | 0 |
| Connective tissue disorder | 0 | 1 |
| Tobacco use | 4 | 6 |
| Immunosuppressive drugs | 1 | 0 |
| Chronic kidney disease | 3 | 5 |
| Coronary artery disease | 4 | 3 |
| Type of prosthesis | ||
| AGILITY™ Revision/LP/Custom-made long-stemmed LP Talar Implant | 18 | 6 |
| INBONE™ II | 17 | 8 |
| SALTO TALARIS™ | 0 | 10 |
| SALTO Talaris XT™ | 0 | 9 |
| Additional number of incisions | 1.0 ± 0.7 | 1.1 ± 1.2 |